Dermasol 0.05% Ointment
75.50৳ Tube (20 gm)
- Dermasol, containing Clobetasol Propionate, treats dermatoses such as psoriasis, lichen planus, and persistent skin conditions resistant to milder steroids.
- Available in cream, ointment, shampoo, lotion, and spray formulations, Dermasol offers versatile application options.
- Clobetasol Propionate acts by reducing inflammation, itching, and allergic reactions through its anti-inflammatory and vasoconstrictive properties.
- Dosage involves applying a thin layer of cream or ointment twice daily for up to two weeks, with different instructions for other formulations.
- Caution is advised in special populations, like children under 12, to prevent adverse effects such as atrophic changes and adrenal suppression.
Brand |
Square Pharmaceuticals PLC |
---|---|
Generics |
Clobetasol Propionate |
Indications
Dermasol is recommended for individuals aged one year and above to treat the following dermatoses:
- Psoriasis (excluding widespread plaque psoriasis)
- Persistent dermatoses
- Lichen planus
- Discoid lupus erythematosus
- Other skin conditions unresponsive to milder steroids
Composition
Dermasol contains Clobetasol Propionate in various formulations including cream, ointment, scalp application, shampoo, lotion, and spray.
Pharmacology
Clobetasol Propionate, a potent topical corticosteroid, possesses anti-inflammatory, antipruritic, and vasoconstrictive properties. It acts by inhibiting late-phase allergic reactions, mast cell density, eosinophil chemotaxis, and cytokine production.
Dosage
For adults, elderly, and children over one year, apply a thin layer of Dermasol cream or ointment twice daily to affected areas, gently rubbing it in. Treatment should be limited to two consecutive weeks. Different dosing instructions apply to the scalp application, shampoo, lotion, and spray formulations.
Administration
Dermasol is for cutaneous use. Creams are suitable for moist or weeping surfaces, while ointments are preferable for dry or scaly lesions.
Interaction
Co-administered drugs inhibiting CYP3A4 may increase systemic corticosteroid exposure.
Contraindications
Avoid in rosacea, acne vulgaris, and perioral dermatitis. Not recommended for children under one year or for primary cutaneous viral infections.
Side Effects
Prolonged use or extensive application may lead to systemic absorption and hypercorticism features. Local atrophic changes, pigmentation changes, and hypertrichosis are possible. Discontinue if hypersensitivity signs appear.
Pregnancy & Lactation
Limited data exists on its use during pregnancy and lactation. Administer only if benefits outweigh risks.
Precautions & Warnings
Long-term continuous therapy, especially in infants and children, should be avoided to prevent adrenal suppression. Care is required when treating facial areas to avoid atrophic changes. Avoid ocular exposure to prevent potential eye issues.
Use in Special Populations
Children under 12 years old are more susceptible to atrophic changes and adrenal suppression.
Overdose Effects
Acute overdosage is unlikely but chronic misuse may lead to hypercortisolism symptoms.
Therapeutic Class
Dermasol belongs to the category of other topical corticosteroids.
Storage Conditions
Store Dermasol below 30°C, away from light and moisture, and out of children’s reach.
Reviews
There are no reviews yet.